Free triiodothyronine (fT3) and B-type natriuretic peptide (BNP) predict in-hospital mortality after valve surgery
- 22 Downloads
Increased B-type natriuretic peptide (BNP) and decreased free triiodothyronine (fT3) are associated with increased mortality after cardiac surgery. However, previous studies have addressed mortality primarily in patients undergoing coronary artery bypass graft, and not in those undergoing valve surgery. We assessed abilities of BNP and fT3 to predict mortality after valve surgery.
This retrospective study included 1050 consecutive patients who underwent valve surgery with normothermic cardiopulmonary bypass (CPB). Predictors of in-hospital mortality were identified with logistic regression analyses. Cutoff values were determined with receiver operating curve analyses.
There were 23 deaths (2.2%). By univariate analyses, fT3, log-transformed BNP (log BNP), cholinesterase, estimated glomerular filtration rate, and albumin were profoundly associated with in-hospital mortality (p < 0.0001 for each). By a multivariate analysis, however, only fT3 and log BNP remained significant (p = 0.0053 and p = 0.0449, respectively). fT3 and log BNP remained significant after adjustment for CPB time, and also after adjustment for the EuroSCORE II or JapanSCORE (p < 0.05 for each). Odds ratio and 95% confidence interval from univariate binary analysis for in-hospital mortality were 7.22 (3.12–17.58) for fT3 ≤ 2.21 pg/mL, 6.01 (2.54–15.77) for BNP ≥ 219 pg/mL, and 9.79 (4.21–22.74) for both combined (p < 0.0001 for each).
fT3 and BNP predict in-hospital mortality after valve surgery, independent of each other, independent of CPB time, and independent of established mortality risk SCOREs. Additions of fT3 and BNP may enhance predictive utilities of established mortality risk SCOREs.
KeywordsB-type natriuretic peptide (BNP) Cardiopulmonary bypass (CPB) Free triiodothyronine (fT3) Heart valve surgery Mortality
We thank all the staff associated with cardiac surgery for their assistance in conducting this study.
Compliance with ethical standards
Conflicts of interest
The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.
- 6.Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, et al. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology. 2010;112:842–51.CrossRefGoogle Scholar
- 16.Yamamoto M, Hayashida M, Kakemizu-Watanabe M, Ando N, Mukaida H, Kawagoe I, et al. B-Type natriuretic peptide and hemoglobin are two major factors significantly associated with baseline cerebral oxygen saturation measured using the INVOS oximeter in patients undergoing off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2018;32:187–96.CrossRefGoogle Scholar
- 23.Brozaitiene J, Mickuviene N, Podlipskyte A, Burkauskas J, Bunevicius R. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. BMC Cardiovasc Disord. 2016;16:45.CrossRefGoogle Scholar
- 26.Ishigaki T, Shingu Y, Katoh N, Wakasa S, Katoh H, Ooka T, et al. Perioperative changes of the slope in the preload recruitable stroke work relationship by a single-beat technique after mitral valve surgery in functional mitral regurgitation with non-ischemic dilated cardiomyopathy. Gen Thorac Cardiovasc Surg. 2019. https://doi.org/10.1007/s11748-019-01164-w.CrossRefPubMedGoogle Scholar